방사성 리간드 치료제·핵의학 진단·표적 항암 방사성의약품 기업
For reference only. Not investment advice. You are solely responsible for your investment decisions.
7/6 · Real-time
No gainers
Of 6 방사성의약품(RPT) 관련주 stocks tracked today, 0 are up and 6 down (avg -3.22%), an overall weak tone. The top gainer is 녹십자 (-0.24%), while 한미약품 (-8.34%) lags the group.
Based on live prices and updated periodically. Not investment advice.
방사성 리간드 치료제·핵의학 진단·표적 항암 방사성의약품 기업 Switch between Korean and US stock tabs below to see live prices.
Based on publicly known business structure. Not investment advice.
방사성의약품(RPT) 관련주 is a key investment theme in 2026. 방사성 리간드 치료제·핵의학 진단·표적 항암 방사성의약품 기업 PFlow tracks 9 related stocks — 6 Korean and 3 US — with live prices in one view.
There are 9 stocks related to 방사성의약품(RPT) 관련주 — 6 Korean and 3 US stocks. Check live prices and performance in the tabs above.
PFlow's 방사성의약품(RPT) 관련주 page (pflow.app/en/theme/radiopharmaceutical) shows Korean and US leading stocks with live price changes. Click any stock to view detailed data.
Korean 방사성의약품(RPT) 관련주 stocks are 6 KOSPI/KOSDAQ-listed companies, while US 방사성의약품(RPT) 관련주 stocks are 3 NASDAQ/NYSE-listed companies. Comparing both helps gauge global demand trends and valuation differences.
There are 9 companies related to 방사성의약품(RPT) 관련주 — 6 Korean and 3 US. Check their live prices and leading stocks in the list above.
※ This page provides price information for companies with business connections to the listed theme. It is not a recommendation to buy or sell any specific stock. Investors are solely responsible for their investment decisions. Please conduct thorough research before investing.